Abstract
Epithelial-mesenchymal transition (EMT) occurs during embryogenesis, carcinoma invasiveness, and metastasis and can be elicited by transforming growth factor-beta (TGF-beta) signaling via intracellular Smad transducers. The molecular mechanisms that control the onset of EMT remain largely unexplored. Transcriptomic analysis revealed that the high mobility group A2 (HMGA2) gene is induced by the Smad pathway during EMT. Endogenous HMGA2 mediates EMT by TGF-beta, whereas ectopic HMGA2 causes irreversible EMT characterized by severe E-cadherin suppression. HMGA2 provides transcriptional input for the expression control of four known regulators of EMT, the zinc-finger proteins Snail and Slug, the basic helix-loop-helix protein Twist, and inhibitor of differentiation 2. We delineate a pathway that links TGF-beta signaling to the control of epithelial differentiation via HMGA2 and a cohort of major regulators of tumor invasiveness and metastasis. This network of signaling/transcription factors that work sequentially to establish EMT suggests that combinatorial detection of these proteins could serve as a new tool for EMT analysis in cancer patients.
MeSH Terms
Animals
Cell Proliferation/drug effects
Epithelial Cells/cytology,drug effects
Gene Expression Regulation/drug effects
HMGA2 Protein/genetics,metabolism
Humans
Mesoderm/cytology,drug effects
Mice
RNA, Messenger/genetics,metabolism
Signal Transduction/drug effects
Smad Proteins/metabolism
Transcription, Genetic/drug effects
Transforming Growth Factor beta/pharmacology
Chemicals
HMGA2 Protein
RNA, Messenger
Smad Proteins
Transforming Growth Factor beta
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Thuault Sylvie
Ludwig Institute for Cancer Research, Uppsala University, SE-751 24 Uppsala, Sweden, and Institut National de la Santé et de la Recherche Médicale, Hôpital E. Herriot, Lyon Cedex, France.
Valcourt Ulrich
Petersen Maj
Manfioletti Guidalberto
Heldin Carl-Henrik
Moustakas Aristidis
References (25)
25 references, click to expand
-
Sp1 and CTF/NF-1 transcription factors are involved in the basal expression of the Hmgi-c proximal promoter.
Biochem Biophys Res Commun. 1999 Nov 19;265(2):439-47
PMID: 10558886
-
Transforming growth factor-beta regulation of immune responses.
Annu Rev Immunol. 2006;24:99-146
PMID: 16551245
-
Enhanceosomes.
Curr Opin Genet Dev. 2001 Apr;11(2):205-8
PMID: 11250145
-
Molecular biology of HMGA proteins: hubs of nuclear function.
Gene. 2001 Oct 17;277(1-2):63-81
PMID: 11602345
-
Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions.
J Biol Chem. 2003 Jun 6;278(23):21113-23
PMID: 12665527
-
The two faces of transforming growth factor beta in carcinogenesis.
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8621-3
PMID: 12861075
-
Smad3 signaling is required for epithelial-mesenchymal transition of lens epithelium after injury.
Am J Pathol. 2004 Feb;164(2):651-63
PMID: 14742269
-
Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.
EMBO J. 2004 Mar 10;23(5):1155-65
PMID: 14976548
-
Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity.
Cancer Res. 2004 Mar 15;64(6):2024-9
PMID: 15026339
-
Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein.
Mol Cell Biol. 2004 May;24(10):4241-54
PMID: 15121845
-
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
Cell. 2004 Jun 25;117(7):927-39
PMID: 15210113
-
Transcriptional regulation of cadherins during development and carcinogenesis.
Int J Dev Biol. 2004;48(5-6):365-75
PMID: 15349812
-
Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer.
FEBS Lett. 2004 Sep 10;574(1-3):1-8
PMID: 15358530
-
A role for Id in the regulation of TGF-beta-induced epithelial-mesenchymal transdifferentiation.
Cell Death Differ. 2004 Oct;11(10):1092-101
PMID: 15181457
-
Inhibition of HMGI-C protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells.
Mol Cell Biol. 1995 Mar;15(3):1545-53
PMID: 7862147
-
Tumor-stroma interactions.
Curr Opin Genet Dev. 2005 Feb;15(1):97-101
PMID: 15661539
-
Kinetic characterization of novel pyrazole TGF-beta receptor I kinase inhibitors and their blockade of the epithelial-mesenchymal transition.
Biochemistry. 2005 Feb 22;44(7):2293-304
PMID: 15709742
-
TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition.
Mol Biol Cell. 2005 Apr;16(4):1987-2002
PMID: 15689496
-
The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it.
Dev Dyn. 2005 Jul;233(3):706-20
PMID: 15937929
-
Non-Smad TGF-beta signals.
J Cell Sci. 2005 Aug 15;118(Pt 16):3573-84
PMID: 16105881
-
Molecular requirements for epithelial-mesenchymal transition during tumor progression.
Curr Opin Cell Biol. 2005 Oct;17(5):548-58
PMID: 16098727
-
The transcriptional repressor Snail promotes mammary tumor recurrence.
Cancer Cell. 2005 Sep;8(3):197-209
PMID: 16169465
-
Specificity and versatility in tgf-beta signaling through Smads.
Annu Rev Cell Dev Biol. 2005;21:659-93
PMID: 16212511
-
The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Cancer Res. 2006 Feb 15;66(4):2202-9
PMID: 16489022
-
Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.
Mol Cell Biol. 2001 Jan;21(2):575-94
PMID: 11134344